Henagliflozin, a diabetes treatment approved in China, may do more than just control blood sugar—it may actually slow ...

Glass tried the injections for his advanced disease, but they did not halt his vision loss. So his ophthalmologist tried ...

Sterling Glass had many health problems as a child—swollen feet, night sweats, nausea and vomiting, unquenchable thirst, and ...

Mounjaro recorded Rs 80 crore in sales in September, trailing only GSK's antibiotic Augmentin, which registered Rs 85 crore ...

Oral bisphosphonate medications like alendronate (Fosamax), may not be absorbed well by the body when they’re taken with ...

A new study finds that GLP-1 medications are linked to lower overall cancer risk, particularly for endometrial and ovarian ...

Ozempic has been approved in India for type 2 diabetes. The blockbuster drug by Danish drugmaker Novo Nordisk has taken the ...

DURAVYU now in Phase 3 for the two largest, multi-billion-dollar retinal disease markets, wet AMD and DME with first patient dosing in pivotal Phase 3 DME trials anticipated in Q1 2026 – – New ...

New study involving GLP-1 receptor agonists - the class of drugs that includes Ozempic - show a clear link to cancer risk that needs further investigation.

According to Mordor Intelligence, cardiovascular drugs market is valued at USD 160.39 billion in 2025 and is projected to ...

Centrally acting agents like phentermine/topiramate and naltrexone/bupropion aid weight reduction but lack MASLD-specific ...